ICU official logo ICU
ICU 1-star rating from Upturn Advisory
LMF Acquisition Opportunities Inc (ICU) company logo

LMF Acquisition Opportunities Inc (ICU)

LMF Acquisition Opportunities Inc (ICU) 1-star rating from Upturn Advisory
$0.36
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/05/2025: ICU (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $1

1 Year Target Price $1

Analysts Price Target For last 52 week
$1 Target price
52w Low $0.29
Current$0.36
52w High $3.07

Analysis of Past Performance

Type Stock
Historic Profit -47.38%
Avg. Invested days 21
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/05/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 12.26M USD
Price to earnings Ratio -
1Y Target Price 1
Price to earnings Ratio -
1Y Target Price 1
Volume (30-day avg) 1
Beta -1
52 Weeks Range 0.29 - 3.07
Updated Date 12/7/2025
52 Weeks Range 0.29 - 3.07
Updated Date 12/7/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.13

Earnings Date

Report Date 2025-11-14
When -
Estimate -0.15
Actual -0.13

Profitability

Profit Margin -
Operating Margin (TTM) -1955.74%

Management Effectiveness

Return on Assets (TTM) -86.54%
Return on Equity (TTM) -290.37%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 8025944
Price to Sales(TTM) 13.91
Enterprise Value 8025944
Price to Sales(TTM) 13.91
Enterprise Value to Revenue 9.11
Enterprise Value to EBITDA -8.13
Shares Outstanding 34096420
Shares Floating 35777862
Shares Outstanding 34096420
Shares Floating 35777862
Percent Insiders 0.75
Percent Institutions 7.1

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

LMF Acquisition Opportunities Inc

LMF Acquisition Opportunities Inc(ICU) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

LMF Acquisition Opportunities Inc. is a special purpose acquisition company (SPAC) founded in 2021. As a SPAC, its primary purpose is to merge with, purchase capital stock, assets, and business units of one or more businesses. It was formed to identify a target business that is likely to be in a growth-oriented sector such as technology, financial technology, or e-commerce. The company raised $100 million in its initial public offering (IPO) in February 2022 and its securities were listed on the Nasdaq Capital Market.

Company business area logo Core Business Areas

  • SPAC Business: As a SPAC, LMF Acquisition Opportunities Inc. does not have traditional core business areas in terms of product or service offerings. Its 'business' is the process of identifying and completing a business combination with a suitable target company. The SPAC structure is designed to facilitate an initial public offering for a private company that might otherwise find it difficult to go public.

leadership logo Leadership and Structure

The leadership team typically consists of experienced professionals with expertise in finance, mergers and acquisitions, and specific industry sectors. Specific names and detailed organizational structure are usually disclosed in SEC filings. As of its IPO, the management team included individuals with backgrounds in investment banking and corporate finance.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Product Name 1: IPO Capital (via Trust Account) - The primary 'offering' of a SPAC is the capital raised through its IPO, held in a trust account, which is then deployed to finance an acquisition. Market share for this 'offering' is not applicable as it's a unique capital raising mechanism for a specific transaction. Competitors are other SPACs seeking target companies.

Market Dynamics

industry overview logo Industry Overview

The SPAC market experienced significant growth and then a contraction in recent years. The industry is characterized by its role in facilitating public listings for private companies, offering an alternative to traditional IPOs. It is heavily influenced by market sentiment, regulatory changes, and the availability of attractive target companies. The current environment sees increased scrutiny and a more cautious approach from investors.

Positioning

LMF Acquisition Opportunities Inc. is positioned as a SPAC seeking to identify and acquire a target company. Its success hinges on its ability to secure a favorable merger agreement with a high-quality target business that offers growth potential to its shareholders. Its competitive advantage lies in the expertise of its management team to source and execute such a transaction.

Total Addressable Market (TAM)

The TAM for SPACs is effectively the universe of private companies seeking to go public and the capital available for such transactions. This is a dynamic market, and estimates vary widely. LMF Acquisition Opportunities Inc. is positioned to participate in this market by seeking a target company within its identified sectors of interest.

Upturn SWOT Analysis

Strengths

  • Experienced management team with M&A expertise.
  • Access to capital raised through IPO ($100 million).
  • Flexibility in identifying target companies across various growth sectors.

Weaknesses

  • As a SPAC, it has no existing operations or revenue streams until a business combination is completed.
  • Dependency on finding a suitable and accretive acquisition target within a limited timeframe.
  • Market perception and investor confidence in the SPAC structure have fluctuated significantly.

Opportunities

  • Acquire a promising private company in a high-growth sector (e.g., fintech, tech, e-commerce).
  • Leverage management's network and expertise to identify undervalued or growth-stage companies.
  • Benefit from potential market upturns that favor growth companies.

Threats

  • Inability to find a suitable acquisition target within the mandated timeframe, leading to dissolution.
  • Increased regulatory scrutiny of SPACs.
  • Deterioration of market conditions or target company's prospects post-acquisition.
  • Competition from other SPACs and traditional IPOs for attractive targets.

Competitors and Market Share

Key competitor logo Key Competitors

  • Other SPACs actively seeking target companies.
  • Investment banks facilitating traditional IPOs.

Competitive Landscape

LMF Acquisition Opportunities Inc. competes with hundreds of other SPACs for attractive acquisition targets. Its advantage lies in its management's ability to identify and negotiate a deal with a company that can deliver shareholder value. The landscape is highly competitive and driven by deal quality and market timing.

Growth Trajectory and Initiatives

Historical Growth: As a SPAC, historical growth is defined by its formation and IPO. There is no operational growth to report.

Future Projections: Future projections are entirely dependent on the acquisition target selected. Analyst estimates will only become relevant after a business combination is announced and the target company's financials and growth prospects are disclosed.

Recent Initiatives: The most significant recent initiative was its IPO in February 2022 and the subsequent search for a target company.

Summary

LMF Acquisition Opportunities Inc. is a SPAC with no current operational business, making its financial health and future prospects entirely contingent on successfully merging with a target company. Its primary strengths lie in its management's M&A expertise and access to IPO capital. However, it faces significant risks related to finding a suitable acquisition, market volatility, and regulatory headwinds. Success hinges on a strategic acquisition that can drive growth and shareholder value.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • SEC Filings (Form S-1, 8-K)
  • Financial news outlets and databases.

Disclaimers:

This information is based on publicly available data and is for informational purposes only. It does not constitute investment advice. SPACs are inherently risky investments, and their performance is highly dependent on the success of the eventual business combination. Investors should conduct their own due diligence before making any investment decisions.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About LMF Acquisition Opportunities Inc

Exchange NASDAQ
Headquaters Denver, CO, United States
IPO Launch date 2022-10-28
CEO, Treasurer, President & Executive Director Mr. Eric Schlorff
Sector Healthcare
Industry Biotechnology
Full time employees 19
Full time employees 19

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.